INDENOLOL PHARMACOKINETICS AND PHARMACODYNAMICS AFTER SINGLE AND REPEATED DAILY DOSES

被引：3

作者：

SEGA, R

MAILLAND, F

COLOMBO, F

GROOTHOLD, G

PANTAROTTO, C

GUENZATI, G

LIBRETTI, A

机构：

[1] POLI RES CTR, MILAN, ITALY

[2] MARIO NEGRI INST PHARMACOL RES, I-20157 MILAN, ITALY

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 25卷 / 05期

关键词：

D O I：

10.1002/j.1552-4604.1985.tb02851.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：337 / 342

页数：6

共 14 条

[1]

CARUTHER.SG, 1974, CLIN PHARMACOL THER, V15, P497

[2]

JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233

[3]

MALACCO E, 1984, 1ST P C IT SOC HYP P

[4] DOSE-RESPONSE STUDIES OF INDENOLOL, A BETA-ADRENOCEPTOR BLOCKER [J].

OKUPA, FE ;

DANESHMEND, TK ;

SHROSBREE, E ;

ROBERTS, CJC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (04) :434-439

[5]

SEGA R, 1983, CURR THER RES CLIN E, V33, P312

[6] INDENOLOL IN HYPERTENSION [J].

SEGA, R ;

MAILLAND, F ;

DAMIANI, E ;

GROOTHOLD, G ;

LIBRETTI, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :289-293

[7]

SHIOBARA Y, UNPUB ABSORPTION DIS

[8]

TACHIKAWA S, 1973, ARCH INT PHARMACOD T, V202, P79

[9]

TAKENAKA F, 1972, FOLIA PHARMACOL JPN, V68, P848

[10]

TAKENAKA T, 1972, ARZNEIMITTEL-FORSCH, V22, P1864

← 1 2 →